The Redwood City, Calif.-based company said it is looking to float approximately 2.2 million shares of its common stock at $1.64 per share, hoping to bring in approximately $3.6 million.
The offering will also include warrants for the purchase of half a share of common stock for each share purchased, with an exercise price of $1.58 per share. Warrants offered in the round will be exercisable for up to six months after the offering closes, and will expire three years from the date they were issued.
Ladenburg Thalmann & Co are acting as the exclusive placement agent for the offering, which the company expects to close on July 16, according to a press release.
Last month, Avinger said it launched its next-generation Pantheris in the US, touting that the first procedures with the device have already been performed.
Heidi Dohse was diagnosed with a rare arrhythmia in 1982 and has been 100% pacemaker dependent for over 30 years. With the help of wearable devices, she has been able to pursue her dream to become a competitive cyclist.
You can hear her story and more when you register for DeviceTalks Boston, October 8-10.
Use code FINISHLINE to save an additional 10%.